CompuGroup Medical Delivers Solid Q1 Performance, Defying Strong Previous Year

• CompuGroup Medical SE & Co. KGaA reported a solid first quarter in 2024, despite revenues being down by 2% compared to the previous year.
• The company saw organic growth of 3% when adjusted for Telematics Infrastructure (TI) one-offs, and recurring revenue share increased to 75%.
• CompuGroup is benefiting from advancing digitization in the German and French healthcare sectors, with a significant increase in the digital exchange of documents.
• The company continues to convert hospital order backlog into revenue and has reduced its leverage to 2.6x.
• In the first quarter of 2024, CompuGroup's recurring revenues grew by 7% to EUR 213 million, accounting for 75% of total revenue. Adjusted EBITDA increased by 1% to EUR 61 million.
• The company has returned to a policy of giving annual guidance only, with an expected organic revenue growth between 4% and 6% and an adjusted EBITDA in a range of EUR 270 million to EUR 310 million for the current financial year.

The next important date, Press release for the quarterly report (as of Q1), at CompuGroup Medical is on 08.05.2024.

The price of CompuGroup Medical at the time of the news was 29,19EUR and was down -0,03 % compared with the previous day.
42 minutes after the article was published, the price was 29,20EUR this corresponds to a plus of +0,03 % since publication.
At this time, the index SDAX was at 14.758,46PKT (+1,52 %).

CompuGroup Medical

-0,42 %

+4,24 %

-2,80 %

-9,06 %

-43,84 %

-55,88 %

-52,78 %

+58,33 %

+3.928,33 %

ISIN:DE000A288904WKN:A28890

• Intraday
• 5 Tage
• 1 Monat
• 3M
• 1 Jahr
• 3J
• 5J
• 10J
• Max